Market Overview:
The global methylphenidate hydrochloride market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of attention deficit hyperactivity disorder (ADHD) and other applications, and rising demand for generic drugs. However, the high cost of branded drugs is restraining the growth of this market. Based on type, the global methylphenidate hydrochloride market is segmented into 99% purity and other types. The 99% purity segment is expected to account for a larger share of the global methylphenidate hydrochloride market in 2018 owing to its higher quality as compared to other types. Based on application, the global methylphenidate hydrochloride market is segmented into ADHD and other applications.
Product Definition:
Methylphenidate hydrochloride is a central nervous system stimulant used in the treatment of attention-deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used as an athletic performance enhancer and cognitive enhancer. Methylphenidate hydrochloride is a white, crystalline powder that is soluble in water and slightly soluble in ethanol.
99% Purity:
99% purity is a very high quality grade of methylphenidate hydrochloride. It has been characterized by LC-MS (liquid chromatography-mass spectrometry) with purest possible instrument, equipment and reagent combination used for the analysis. The method provides accurate results in lesser time and it's considered as one of the best methods to determine 99% Purity based on mass spectrum taken from an HPLC run with no interference from other compounds.
Other:
Other is used as a generic name for any drug or medication and can be used interchangeably with the word “interchangeable”. The other drug or medication can be any pharmaceutical product that is not an approved prescription drug in the U.S. and/or has not been through clinical trials to prove its safety for use by humans. Other drugs are usually found in OTC products such as cough syrups, pain relievers, vitamins, etc.
Application Insights:
The global methylphenidate hydrochloride market is segmented based on application into attention deficit hyperactivity disorder (ADHD), other disorders. The other applications include narcolepsy, bipolar disorder and depression. ADHD was the largest segment in 2017 and is expected to maintain its dominance throughout the forecast period due to high prevalence of this condition coupled with increasing awareness about diagnosis and treatment options. According to a survey conducted by the Centers for Disease Control and Prevention (CDC) in 2016, around 36% of children aged 4-17 years were diagnosed with ADHD while 6% of U.S children had symptoms meeting criteria during 2014-2016 which indicates there are still room for growth despite high prevalence rates.
In 2015, pharmaceutical companies including Pfizer Inc.
Regional Analysis:
North America was the largest market for global methylphenidate hydrochloride, accounting for more than 60% of total market volume in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing R&D investments by various pharmaceutical companies and rising prevalence of attention-deficit/hyperactivity disorder (ADHD) in U.S., which has led to increased demand for medicines that improve focus and concentration levels among children & adolescents as well as adults. Moreover, presence of key manufacturers such as Cephalon Inc.; Sun Pharmaceutical Industries Ltd.; Shire; Mylan N.V.
Growth Factors:
- Increasing prevalence of ADHD: The major growth driver for the methylphenidate hydrochloride market is the increasing prevalence of ADHD. According to a study by the Centers for Disease Control and Prevention (CDC), around 11% of children aged 4-17 years in the U.S. have been diagnosed with ADHD as of 2011. This number is expected to grow in future, owing to increasing awareness about ADHD and its diagnosis among parents and healthcare professionals.
- Growing use of methylphenidate hydrochloride in adults: Another key growth driver for this market is the growing use of methylphenidate hydrochloride in adults, especially those suffering from narcolepsy or chronic fatigue syndrome (CFS). Methylphenidate has been found to be effective in treating these conditions and its use is growing rapidly among adults worldwide.
- Availability of generic versions: The availability of generic versions of methylphenidate hydrochloride drugs at lower prices has helped make them more affordable and accessible to a larger population worldwide, thus driving market growth significantly over the past few years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Methylphenidate Hydrochloride Market Research Report
By Type
99% Purity, Other
By Application
Attention Deficit Hyperactivity Disorder, Other
By Companies
ZCL Chemicals, SCI Pharmtech, Midas Pharma, Taj Pharma, Noramco
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Methylphenidate Hydrochloride Market Report Segments:
The global Methylphenidate Hydrochloride market is segmented on the basis of:
Types
99% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Attention Deficit Hyperactivity Disorder, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ZCL Chemicals
- SCI Pharmtech
- Midas Pharma
- Taj Pharma
- Noramco
Highlights of The Methylphenidate Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% Purity
- Other
- By Application:
- Attention Deficit Hyperactivity Disorder
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methylphenidate Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methylphenidate hydrochloride is a stimulant medication used to treat attention deficit hyperactivity disorder (ADHD). It works by increasing the levels of dopamine in the brain.
Some of the major players in the methylphenidate hydrochloride market are ZCL Chemicals, SCI Pharmtech, Midas Pharma, Taj Pharma, Noramco.
The methylphenidate hydrochloride market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Methylphenidate Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Methylphenidate Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Methylphenidate Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Methylphenidate Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Methylphenidate Hydrochloride Market Size & Forecast, 2020-2028
4.5.1 Methylphenidate Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Methylphenidate Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 99% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Attention Deficit Hyperactivity Disorder
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Methylphenidate Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Methylphenidate Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 99% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Attention Deficit Hyperactivity Disorder
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 99% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Attention Deficit Hyperactivity Disorder
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 99% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Attention Deficit Hyperactivity Disorder
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 99% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Attention Deficit Hyperactivity Disorder
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 99% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Attention Deficit Hyperactivity Disorder
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Methylphenidate Hydrochloride Market: Competitive Dashboard
14.2 Global Methylphenidate Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ZCL Chemicals
14.3.2 SCI Pharmtech
14.3.3 Midas Pharma
14.3.4 Taj Pharma
14.3.5 Noramco
